Hemoglobin in Acute Leukemias - Brief report , ISSN 2753-8176 (online)

Hemoglobin in Acute Leukemias, Brief Report

Ana Pedro (1)

1. Gwyntwr1386 Pharmacy, Regus Chester Business Park, Heronsway,Chester CH4 9QR, United Kingdom info@gwyntwr1386.com

Introduction

Acute myeloid leukemia (AML) is a cancer of the myeloid line of blood cells, where there is a rapid growth of abnormal cells that build up in the bone marrow and blood interfering with normal blood cell production (1). Here, we analyze by proteomic analysis the precipitates after ultra-centrifugation of the conditioned media resulting from the cell culture of OCI-AML3 and Kasumi1 cell lines. We compare these proteomic profiles with those derived from the precipitates after ultra-centrifugation of plasma samples of control adult males (Control plasma male 1 and Control plasma male 2) OCI-AML3 cell line is derived from a 57 year-old male with Adult acute myeloid leukemia (2). Kasumi1 cell line is derived from the peripheral blood of a male AML patient, 7 weeks old (3).

Results and Discussion

We found out that (table 1, HBG1, hemoglobin gamma-1)), HBA (hemoglobin alpha), Mascot scores are raised in leukemia samples, while HBB (hemoglobin beta) Mascot scores are lower in leukemia samples. Also, HBD (hemoglobin delta) only is present in control samples.

Material and Methods

Proteomic analysis was performed at the Rockefeller University, Proteomics Center as described in Hamidi et al., 2017 (4). Only proteins with Mascot scores of approximately 90 or >90 were considered (5) The proteomic analysis excel files and each correspondent sample details were generously and kindly shared and donated by Dr. David Lyden, Weill Cornell Medical College, New York, USA. Original data files can be found at https://zenodo.org/record/8108731

References

1."Adult Acute Myeloid Leukemia Treatment". National Cancer Institute. 6 March 2017. Retrieved 19 December 2017.

2.https://www.cellosaurus.org/CVCL_1844

3.https://www.atcc.org/products/crl-2724

4. https://www.biorxiv.org/content/10.1101/202291v1

5.https://f1000research.com/articles/7-283

Comments

Popular posts from this blog

An E-Medicine Delivery and Treatment Monitoring Service For Patients With Type-2 Diabetes In The NHS - Project proposal ((ISSN 2753-8176 (online)

A triage centre and a medicine delivery and treatment monitoring service for patients with heart disease/ hypertension/diabetes using the NHS App for the NHS (ISSN 2753-8176 (online))

AN HEMOGLOBIN TEST FOR CANCER SCREENING (ISSN 2753-8176 (online))